Point72 Hong Kong LTD Edwards Lifesciences Corp Call Options Transaction History

Point72 Hong Kong LTD

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $181,214 - $236,038	2,200 Added 95.65%	4,500 $372,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $181,214 - $236,038	2,200 Added 95.65%	4,500 $372,000
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $285,450 - $423,291	-3,300 Reduced 58.93%	2,300 $219,000
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $382,932 - $470,448	3,600 Added 180.0%	5,600 $725,000
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $751,243 - $896,075	-7,300 Reduced 78.49%	2,000 $226,000
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $666,717 - $848,439	9,300 New	9,300 $848,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.